Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To all shareholders, please read:

I am happy to see such a positive step taken and it is very encouraging to see action rather than the endless talk-about-talk-about-talk inaction.

Kindly clarify the difference in the two systems should there be five nominees for five vacant places on a BoD, bearing in mind that a withheld vote is not construed as a vote against, using the numbers from last year.

Good luck with the proposal.

Incidentally, how does this proposal relate to the topic at the time of including additional nominees for BoD positions?

.

.

.

Be well

Share
New Message
Please login to post a reply